Global Wealth Management Investment Advisory’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30
Closed -$6K 173
2022
Q2
$6K Hold
30
﹤0.01% 319
2022
Q1
$6K Hold
30
﹤0.01% 352
2021
Q4
$7K Sell
30
-10
-25% -$2.57K ﹤0.01% 336
2021
Q3
$11K Hold
40
﹤0.01% 304
2021
Q2
$14K Hold
40
﹤0.01% 268
2021
Q1
$11K Sell
40
-3
-7% -$809 ﹤0.01% 301
2020
Q4
$11K Hold
43
﹤0.01% 269
2020
Q3
$12K Sell
43
-636
-94% -$177K 0.01% 263
2020
Q2
$182K Sell
679
-346
-34% -$104K 0.08% 116
2020
Q1
$324K Sell
1,025
-73
-7% -$22.2K 0.16% 89
2019
Q4
$326K Buy
1,098
+16
+1% +$4.44K 0.14% 95
2019
Q3
$252K Buy
1,082
+9
+0.8% +$2.1K 0.12% 98
2019
Q2
$251K Buy
1,073
+255
+31% +$58.9K 0.12% 96
2019
Q1
$193K Buy
818
+125
+18% +$39.4K 0.1% 118
2018
Q4
$209K Buy
+693
New +$221K 0.12% 130

Other funds holding BIIB

Global Wealth Management Investment Advisory's BIIB Position: Q3 2022 in Review

Global Wealth Management Investment Advisory sold out of Biogen (BIIB) in Q3 2022, closing a stake of 30 shares — an estimated $6K sold.

Global Wealth Management Investment Advisory first reported a position in BIIB in Q4 2018 and held it in 15 quarters. The position peaked at $326K in Q4 2019. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Global Wealth Management Investment Advisory reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 30 Biogen shares in Q3 2022, an estimated $6K.
  • Global Wealth Management Investment Advisory first reported a position in Biogen in Q4 2018 and held it in 15 quarters.
  • Global Wealth Management Investment Advisory's Biogen position peaked at $326K in Q4 2019.
  • 987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Global Wealth Management Investment Advisory's 13F filing for Q3 2022, filed 19 Oct 2022.